Published in Virology on August 01, 1989
Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol (1990) 2.21
Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles. J Virol (2000) 1.90
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol (2004) 1.80
Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein. J Virol (1994) 1.68
Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci U S A (2004) 1.66
Assembly of spikes into coronavirus particles is mediated by the carboxy-terminal domain of the spike protein. J Virol (2000) 1.34
Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J Virol (1992) 1.24
Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2. J Virol (1993) 1.22
Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion. J Virol (1999) 1.19
Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus. Proc Natl Acad Sci U S A (2004) 1.12
Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement. J Virol (1995) 1.07
The coronavirus transmissible gastroenteritis virus causes infection after receptor-mediated endocytosis and acid-dependent fusion with an intracellular compartment. J Virol (1998) 1.00
Characterization of two temperature-sensitive mutants of coronavirus mouse hepatitis virus strain A59 with maturation defects in the spike protein. J Virol (1997) 0.92
Inhibitory effects of recombinant human cystatin C on human coronaviruses. Antimicrob Agents Chemother (1991) 0.89
Feline and canine coronaviruses: common genetic and pathobiological features. Adv Virol (2011) 0.82
The evolutionary processes of canine coronaviruses. Adv Virol (2011) 0.79
Coronaviruses: structure and genome expression. J Gen Virol (1988) 4.77
Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59). Virology (1981) 4.01
An automated genotyping tool for enteroviruses and noroviruses. J Clin Virol (2011) 3.80
Equine arteritis virus is not a togavirus but belongs to the coronaviruslike superfamily. J Virol (1991) 3.35
Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J (1996) 3.33
Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. Euro Surveill (2013) 3.11
Flaviviridae. Intervirology (1985) 3.06
Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology (1988) 2.83
Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol (1998) 2.74
The primary structure and expression of the second open reading frame of the polymerase gene of the coronavirus MHV-A59; a highly conserved polymerase is expressed by an efficient ribosomal frameshifting mechanism. Nucleic Acids Res (1990) 2.71
Translation of three mouse hepatitis virus strain A59 subgenomic RNAs in Xenopus laevis oocytes. J Virol (1981) 2.69
Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59. Virology (1989) 2.69
Recent advances in pestivirus research. J Gen Virol (1989) 2.67
Synthesis of subgenomic mRNA's of mouse hepatitis virus is initiated independently: evidence from UV transcription mapping. J Virol (1981) 2.65
Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication. J Virol (1999) 2.49
Arterivirus discontinuous mRNA transcription is guided by base pairing between sense and antisense transcription-regulating sequences. Proc Natl Acad Sci U S A (1999) 2.42
Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J Virol (1994) 2.27
Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin. J Virol (1981) 2.27
Structural proteins of equine arteritis virus. J Virol (1992) 2.23
Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol (1990) 2.21
Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology (1987) 2.16
The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus. Virology (1996) 2.15
A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J Virol (1991) 2.14
An infectious arterivirus cDNA clone: identification of a replicase point mutation that abolishes discontinuous mRNA transcription. Proc Natl Acad Sci U S A (1997) 2.11
Laboratory-based surveillance in the molecular era: the TYPENED model, a joint data-sharing platform for clinical and public health laboratories. Euro Surveill (2013) 2.07
Evidence for a coiled-coil structure in the spike proteins of coronaviruses. J Mol Biol (1987) 2.07
Proteolytic processing of the replicase ORF1a protein of equine arteritis virus. J Virol (1994) 2.03
[Acyclovir freely obtainable]. Ned Tijdschr Geneeskd (1996) 2.03
Togaviridae. Intervirology (1985) 1.96
Emergence of a novel GII.17 norovirus – End of the GII.4 era? Euro Surveill (2015) 1.92
Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation. J Virol (1994) 1.85
Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006. J Clin Microbiol (2008) 1.80
Envelope glycoprotein interactions in coronavirus assembly. J Cell Biol (1995) 1.79
Sequence relationships between the genome and the intracellular RNA species 1, 3, 6, and 7 of mouse hepatitis virus strain A59. J Virol (1982) 1.78
The influence of downstream protein-coding sequence on internal ribosome entry on hepatitis C virus and other flavivirus RNAs. RNA (2001) 1.77
Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy (1997) 1.76
Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J Virol (1991) 1.75
Sequence requirements for RNA strand transfer during nidovirus discontinuous subgenomic RNA synthesis. EMBO J (2001) 1.75
Coronavirus particle assembly: primary structure requirements of the membrane protein. J Virol (1998) 1.74
All subgenomic mRNAs of equine arteritis virus contain a common leader sequence. Nucleic Acids Res (1990) 1.74
The arterivirus replicase is the only viral protein required for genome replication and subgenomic mRNA transcription. J Gen Virol (2000) 1.72
The molecular genetics of feline coronaviruses: comparative sequence analysis of the ORF7a/7b transcription unit of different biotypes. Virology (1995) 1.68
The carboxyl-terminal part of the putative Berne virus polymerase is expressed by ribosomal frameshifting and contains sequence motifs which indicate that toro- and coronaviruses are evolutionarily related. Nucleic Acids Res (1990) 1.68
The putative helicase of the coronavirus mouse hepatitis virus is processed from the replicase gene polyprotein and localizes in complexes that are active in viral RNA synthesis. J Virol (1999) 1.67
Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J Virol (1990) 1.66
Phylogeny of antigenic variants of avian coronavirus IBV. Virology (1989) 1.65
Homologous RNA recombination allows efficient introduction of site-specific mutations into the genome of coronavirus MHV-A59 via synthetic co-replicating RNAs. Nucleic Acids Res (1992) 1.64
Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E. J Virol (2000) 1.64
The 5' end of the equine arteritis virus replicase gene encodes a papainlike cysteine protease. J Virol (1992) 1.61
The arterivirus Nsp2 protease. An unusual cysteine protease with primary structure similarities to both papain-like and chymotrypsin-like proteases. J Biol Chem (1995) 1.60
The influence of AUG codons in the hepatitis C virus 5' nontranslated region on translation and mapping of the translation initiation window. Virology (1996) 1.59
Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol (2007) 1.58
Bunyaviruses and Bunyaviridae. Intervirology (1976) 1.58
O-glycosylation of the coronavirus M protein. Differential localization of sialyltransferases in N- and O-linked glycosylation. J Biol Chem (1992) 1.57
Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR. J Clin Microbiol (1995) 1.57
Mutational analysis of the murine coronavirus spike protein: effect on cell-to-cell fusion. Virology (1995) 1.54
Processing of the equine arteritis virus replicase ORF1b protein: identification of cleavage products containing the putative viral polymerase and helicase domains. J Virol (1996) 1.53
Toroviruses of animals and humans: a review. Adv Virus Res (1994) 1.50
Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins. J Virol (1993) 1.50
The fitness of defective interfering murine coronavirus DI-a and its derivatives is decreased by nonsense and frameshift mutations. J Virol (1992) 1.49
Alternative proteolytic processing of the arterivirus replicase ORF1a polyprotein: evidence that NSP2 acts as a cofactor for the NSP4 serine protease. J Virol (1997) 1.47
Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus. J Clin Microbiol (1996) 1.46
Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. J Infect Dis (1994) 1.44
Equine arteritis virus subgenomic mRNA synthesis: analysis of leader-body junctions and replicative-form RNAs. J Virol (1996) 1.43
Antigenic relationships among homologous structural polypeptides of porcine, feline, and canine coronaviruses. Infect Immun (1982) 1.43
Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect (2006) 1.41
Increase in norovirus activity reported in Europe. Euro Surveill (2006) 1.41
Guidelines for the vaccination of dogs and cats. Compiled by the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA). J Small Anim Pract (2007) 1.41
Regulation of coronavirus mRNA transcription. J Virol (1995) 1.40
Differential premature termination of transcription as a proposed mechanism for the regulation of coronavirus gene expression. Nucleic Acids Res (1988) 1.40
Mice lacking IL-12 develop polarized Th1 cells during viral infection. J Immunol (1998) 1.38
Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis (1995) 1.37
The arterivirus nsp4 protease is the prototype of a novel group of chymotrypsin-like enzymes, the 3C-like serine proteases. J Biol Chem (1996) 1.37
Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein. J Virol (1999) 1.37
Purification and partial characterization of a new enveloped RNA virus (Berne virus). J Gen Virol (1983) 1.37
Comment on "Patel JR, Heldens JGM. Review of companion animal viral diseases and immunoprophylaxis" (Vaccine 2009;27:491-504). Vaccine (2009) 1.37
The peplomer protein sequence of the M41 strain of coronavirus IBV and its comparison with Beaudette strains. Virus Res (1986) 1.37
Swine-like hepatitis E viruses are a cause of unexplained hepatitis in the Netherlands. J Viral Hepat (2007) 1.36
Membrane assembly of the triple-spanning coronavirus M protein. Individual transmembrane domains show preferred orientation. J Biol Chem (1992) 1.35
Enhancement of the vaccinia virus/phage T7 RNA polymerase expression system using encephalomyocarditis virus 5'-untranslated region sequences. Gene (1991) 1.34
Assembly of spikes into coronavirus particles is mediated by the carboxy-terminal domain of the spike protein. J Virol (2000) 1.34
Persistence and evolution of feline coronavirus in a closed cat-breeding colony. Virology (1997) 1.32
Assembly of the coronavirus envelope: homotypic interactions between the M proteins. J Virol (2000) 1.30
Oligomerization of a trans-Golgi/trans-Golgi network retained protein occurs in the Golgi complex and may be part of its retention. J Biol Chem (1995) 1.30